Contact
searchSearch
HMP Global

Volume 15 - Issue 7 - July, 2003

Electrophysiology Corner
A Unique Pacemaker Complication of Thrombus Formation in the Right Internal Jugular Vein Due to Unusual Migration of an Atrial Pacemaker Electrode
04/23/2012
Thomas S. Faber, MD; Andreas Grom, MD; Manfred Zehender, MD
ABSTRACT: Our report describes the late migration of an atrial screw-in lead into the right internal jugular vein causing subsequent subclinical thrombus formation at the tip of the electrode. Previously initiated anticoagulation for atrial...
ABSTRACT: Our report describes the late migration of an atrial screw-in lead into the right internal jugular vein causing subsequent subclinical thrombus formation at the tip of the electrode. Previously initiated anticoagulation for atrial...
ABSTRACT: Our report describes...
04/23/2012
Journal of Invasive Cardiology
Editorial Message
Editor`s Message (May 2003)
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, brief reviews, and articles from the Journal special sections “Acute Coronary Syndromes”, “Clinical Decision Making”, and the...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, brief reviews, and articles from the Journal special sections “Acute Coronary Syndromes”, “Clinical Decision Making”, and the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Commentary
Identifying the Vulnerable Plaque (IAGS Proceedings - Part II of II)
08/01/2008
Klemens Barth, MD; Mike Cowley, MD; James P. Zidar, MD
(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....
(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....
(IAGS Proceedings - Part II of...
08/01/2008
Journal of Invasive Cardiology
Case Report
Delayed Development of a Giant Coronary Pseudoaneurysm After Stent Placement for Chronic Total Occlusion
08/01/2008
Koichi Kishi, MD; Takefumi Takahashi, MD; Yoshikazu Hiasa, MD
Coronary artery aneurysms have been identified in up to 5% of all coronary angiographic studies. Atherosclerotic, congenital, inflammatory, infectious and traumatic (resulting from coronary intervention) are the most common etiologies....
Coronary artery aneurysms have been identified in up to 5% of all coronary angiographic studies. Atherosclerotic, congenital, inflammatory, infectious and traumatic (resulting from coronary intervention) are the most common etiologies....
Coronary artery aneurysms have...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Rare Combination of Left Main Coronary Artery Fistula to Left Superior Vena Cava with Drainage into the Coronary Sinus in a 74
08/01/2008
Amgad N. Makaryus, MD; Richard Stechel, MD; Stephen Green, MD
It is thought that most coronary artery fistulae are congenital in origin, resulting from the persistence of intratrabecular sinusoids during embryonic development.1,2 The persistence of these sinusoids results in the communication between...
It is thought that most coronary artery fistulae are congenital in origin, resulting from the persistence of intratrabecular sinusoids during embryonic development.1,2 The persistence of these sinusoids results in the communication between...
It is thought that most coronary...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Management of Iliac Stent Movement Complicating Peripheral Vascular Intervention: A Rescue Technique When Stent Deployment Malfu
08/01/2008
Morton J. Kern, MD, MSCAI, FACC, FAHA; Walter A. Parham, MD; Sanjeev Puri, MD; Saad R. Bitar, MD
ABSTRACT: Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, has become an effective, accepted, and safe approach for treating intermittent claudication and critical leg ischemia in selected patients....
ABSTRACT: Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, has become an effective, accepted, and safe approach for treating intermittent claudication and critical leg ischemia in selected patients....
ABSTRACT: Percutaneous...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
In-Hospital Complications of Peripheral Vascular Interventions Using Unfractionated Heparin as the Primary Anticoagulant
08/01/2008
Monica Youngblut, RN; Melodee Harris, RN, BSc; Vickie S. Takes, RT(R), CCRC, RN; Jane Holden, RN; Jon H. Lemke, PhD, MD; Matthew J. Kapalis, DO, BA, BSc, BS; Eric J. Dippel, MD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; Catherine Harb, BS; Dawn E. McKinney, MA
Unfractionated heparin is the current antithrombotic of choice in peripheral vascular interventions. Heparin has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activates...
Unfractionated heparin is the current antithrombotic of choice in peripheral vascular interventions. Heparin has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activates...
Unfractionated heparin is the...
08/01/2008
Journal of Invasive Cardiology
Case Report
The Use of the X-Sizer‚Ñ¢ Transluminal Extraction Catheter as an Adjunct to Stenting of Occluded Saphenous Vein Grafts
08/01/2008
Nicholas M. Robinson, MD, MRCP; Philip C. Strike, MD; Duncan S. Dymond, MD
Within a decade of surgery, half of all aortocoronary saphenous vein grafts (SVGs) are totally occluded or have severe atherosclerotic disease.1 Redo coronary artery bypass surgery (CABG) has higher mortality and morbidity than the first...
Within a decade of surgery, half of all aortocoronary saphenous vein grafts (SVGs) are totally occluded or have severe atherosclerotic disease.1 Redo coronary artery bypass surgery (CABG) has higher mortality and morbidity than the first...
Within a decade of surgery, half...
08/01/2008
Journal of Invasive Cardiology
Safety and Efficacy of Low-Dose Intravenous Enoxaparin and Glycoprotein IIb/IIIa Inhibitor Therapy During Percutaneous Coronary
08/01/2008
Louis Carnendran, MD; Robert Borkowski, MD; Bashar Markabawi, MD; Mark F. Warner, MD
Enoxaparin, a low molecular weight heparin, has demonstrated superior efficacy over unfractionated heparin (UFH) in the medical management of acute coronary syndromes (ACS), e.g., unstable angina and non-ST elevation myocardial infarction.1...
Enoxaparin, a low molecular weight heparin, has demonstrated superior efficacy over unfractionated heparin (UFH) in the medical management of acute coronary syndromes (ACS), e.g., unstable angina and non-ST elevation myocardial infarction.1...
Enoxaparin, a low molecular...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Management of Iliac Stent Movement<br />
Complicating Peripheral Vascular Intervention: A Rescue Technique When Stent Deployment<br />
Mal
08/01/2008
Saad R. Bitar, MD; Morton J. Kern, MD, MSCAI, FACC, FAHA; Walter A. Parham, MD; Sanjeev Puri, MD
Although percutaneous intervention for the treatment of peripheral vascular disease for symptomatic intermittent claudication is now considered a safe and common practice, such interventions may be compromised by stent deployment malfunction...
Although percutaneous intervention for the treatment of peripheral vascular disease for symptomatic intermittent claudication is now considered a safe and common practice, such interventions may be compromised by stent deployment malfunction...
Although percutaneous...
08/01/2008
Journal of Invasive Cardiology
Commentary
Identifying the Vulnerable Plaque (IAGS Proceedings - Part I of II parts)
08/01/2008
Klemens Barth, MD; Mike Cowley, MD; James P. Zidar, MD
Jim Zidar: We have chosen magnetic resonance imaging as our primary imaging tool at Duke University. A new cardiac magnetic resonance imaging research laboratory is being installed at Duke, with an adjacent clinical laboratory. In our view,...
Jim Zidar: We have chosen magnetic resonance imaging as our primary imaging tool at Duke University. A new cardiac magnetic resonance imaging research laboratory is being installed at Duke, with an adjacent clinical laboratory. In our view,...
Jim Zidar: We have chosen...
08/01/2008
Journal of Invasive Cardiology
Platelets and Antiplatelet Therapy in Patients with Diabetes Mellitus
08/01/2008
Heidar Arjomand, MD; Bassam Roukoz, MD; Satish K. Surabhi, MD; Marc S. Cohen, MD
Both insulin-dependent and non-insulin dependent diabetes mellitus (DM) are powerful and independent risk factors for coronary artery disease (CAD). In patients with diabetes, the risk of CAD is increased two- to four-fold. Atherosclerotic...
Both insulin-dependent and non-insulin dependent diabetes mellitus (DM) are powerful and independent risk factors for coronary artery disease (CAD). In patients with diabetes, the risk of CAD is increased two- to four-fold. Atherosclerotic...
Both insulin-dependent and...
08/01/2008
Journal of Invasive Cardiology
Commentary
The Search for Optimal Combination of Antiplatelet and Anticoagulation Regimens Following PCI
08/01/2008
Rafael Beyar, MD, DSc, MPH; Luis Gruberg, MD
“The patient is given aspirin (1.0 g per day) for 3 days, starting the day before the procedure. Heparin and low molecular weight dextran are administered during dilatation; warfarin is started after the procedure and is continued until...
“The patient is given aspirin (1.0 g per day) for 3 days, starting the day before the procedure. Heparin and low molecular weight dextran are administered during dilatation; warfarin is started after the procedure and is continued until...
“The patient is given aspirin...
08/01/2008
Journal of Invasive Cardiology
Commentary
Heparin in Peripheral Vascular Intervention — Time for a Change?
08/01/2008
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Throughout the history of interventional procedures, unfractionated heparin has been the standard anticoagulant.1 More recently, in coronary intervention, agents have been found to provide better efficacy and/or safety than sole therapy with...
Throughout the history of interventional procedures, unfractionated heparin has been the standard anticoagulant.1 More recently, in coronary intervention, agents have been found to provide better efficacy and/or safety than sole therapy with...
Throughout the history of...
08/01/2008
Journal of Invasive Cardiology
Case Report
The Diagnostic Importance of Angiographic Visualization of the Distal Vessel in Elucidating the Mechanism of Abrupt Vessel Closu
08/01/2008
Shmuel Fuchs, MD; Jean Marc Weinstein, MRCP; Carlos Cafri, MD; Georgeta Esanu, MD; Reuben Illia, MD; Osvaldo Slutzky, MD
Acute vessel closure is a serious event, complicating 0.5–9.3% of percutaneous coronary interventions (PCI), and is associated with major clinical adverse events including emergency coronary bypass surgery, acute myocardial infarction and...
Acute vessel closure is a serious event, complicating 0.5–9.3% of percutaneous coronary interventions (PCI), and is associated with major clinical adverse events including emergency coronary bypass surgery, acute myocardial infarction and...
Acute vessel closure is a...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Safety and Efficacy of Low-Dose Intravenous Enoxaparin and Glycoprotein IIb/IIIa Inhibitor Therapy During Percutaneous Coronary
08/01/2008
Louis Carnendran, MD; Robert Borkowski, MD; Bashar Markabawi, MD; Mark F. Warner, MD
ABSTRACT: The use of intravenous enoxaparin, a glycoprotein (GP) IIb/IIIa inhibitor, during percutaneous coronary intervention (PCI) has been shown to be safe and to possibly reduce in-hospital and 30-day major adverse cardiac events (MACE)....
ABSTRACT: The use of intravenous enoxaparin, a glycoprotein (GP) IIb/IIIa inhibitor, during percutaneous coronary intervention (PCI) has been shown to be safe and to possibly reduce in-hospital and 30-day major adverse cardiac events (MACE)....
ABSTRACT: The use of intravenous...
08/01/2008
Journal of Invasive Cardiology
Commentary
Atrial Fibrillation: Don’t Become a Basket Case
08/01/2008
Todd J. Cohen, MD, FACC, FHRS
Dr. Karch and colleagues describe the results of right atrial mapping with a 64-pole basket catheter during persistent, induced sustained, and nonsustained atrial fibrillation. One implication which may be gathered from their report is that...
Dr. Karch and colleagues describe the results of right atrial mapping with a 64-pole basket catheter during persistent, induced sustained, and nonsustained atrial fibrillation. One implication which may be gathered from their report is that...
Dr. Karch and colleagues...
08/01/2008
Journal of Invasive Cardiology
Case Report
Refractory Vasomotor Angina in the Setting of Subclinical Hyperthyroidism: A Case Report Demonstrating Both Focal and Segmental
08/01/2008
Allison DeTommasi, MD; Scott Rogge, MD; Jan Laws Houghton, MD
Vasomotor angina is a diagnostically and therapeutically challenging cause of myocardial ischemia. In many cases, affected patients undergo multiple hospitalizations and complex invasive testing, without a definitive diagnosis for years. Even...
Vasomotor angina is a diagnostically and therapeutically challenging cause of myocardial ischemia. In many cases, affected patients undergo multiple hospitalizations and complex invasive testing, without a definitive diagnosis for years. Even...
Vasomotor angina is a...
08/01/2008
Journal of Invasive Cardiology
Adjunctive Use of Cutting Balloon After Rotational Atherectomy in a Young Adult with Probable Kawasaki Disease
08/01/2008
Takeshi Suzuki, MD, PhD; Shigenori Ito, MD; Takahiko Suzuki, MD
Case description. A 19-year-old man, who probably suffered from Kawasaki disease (KD) from 3 years of age, presented with acute myocardial infarction and was treated with direct plain old balloon angioplasty at another hospital. Emergency...
Case description. A 19-year-old man, who probably suffered from Kawasaki disease (KD) from 3 years of age, presented with acute myocardial infarction and was treated with direct plain old balloon angioplasty at another hospital. Emergency...
Case description. A 19-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Simultaneous Multisite Endocardial Mapping of Sustained and Non-Sustained Atrial Fibrillation in Humans
08/01/2008
Claus Schmitt, MD; Michael Schneider; Martin R. Karch, MD; Gjin Ndrepepa, MD; Bernhard Zrenner, MD; Christoph Saur, MD; Albert Schemig, MD
In the past, atrial fibrillation (AF) was regarded as an arrhythmia caused by multiple wavelets rotating in a totally random fashion around both atria. Recent studies, however, show that a variable amount of organization is involved in the...
In the past, atrial fibrillation (AF) was regarded as an arrhythmia caused by multiple wavelets rotating in a totally random fashion around both atria. Recent studies, however, show that a variable amount of organization is involved in the...
In the past, atrial fibrillation...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO&nbsp;–&nbsp;Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering&nbsp;Cleerly®&nbsp;LABS plaque analysis effective immediately. Aetna, which covers more than&nbsp;20+ million lives,...
DENVER, CO&nbsp;–&nbsp;Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering&nbsp;Cleerly®&nbsp;LABS plaque analysis effective immediately. Aetna, which covers more than&nbsp;20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its&nbsp;FDA 510(k)-cleared cvi42&nbsp;with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its&nbsp;FDA 510(k)-cleared cvi42&nbsp;with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris&nbsp;– HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received&nbsp;CE Mark approval&nbsp;for the HighLife Transcatheter Mitral Valve Replacement...
Paris&nbsp;– HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received&nbsp;CE Mark approval&nbsp;for the HighLife Transcatheter Mitral Valve Replacement...
Paris&nbsp;– HighLife SAS, a...
01/27/2026
Cath Lab Digest

July 2003 Volume 15 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use